On air · 3 of 3 networks
Fresenius Kabi USA
- fresenius-kabi.com
- Healthcare & Life Sciences
- US
- 1,802 employees
Fresenius Kabi USA’s ads on LinkedIn, Meta and Google, recorded by adsrunning. Browse the latest here for free. Sign up free to see all 24. Watch Fresenius Kabi USA with Starter to get each new one in your feed.
Watchlist with Starter · $49/mo
| Network | Status | Live ads | Nov 2025LinkedIn activity · 52 weeksOct 2026 | Checked | Next step |
|---|---|---|---|---|---|
| Running | 14 | Checked 28 Oct 2026 | See all 24 ads → | ||
| Meta | Running | 10 | Active ads on the Meta Ad Library, all countries | Checked 28 Oct 2026 | Collect them with the API → |
| Running | 79 | Ads on the Google Ads Transparency Center | Checked 28 Oct 2026 | Collect them with the API → |
Fresenius Kabi USA has 14 live LinkedIn ads. Its Facebook page had 10 active ads on 28 Oct 2026, and we recorded 79 Google ads on 28 Oct 2026.
Latest ads
- LINKEDIN · JOBSince 6 Apr 2026
- LINKEDIN · IMAGERecorded 19 Sept 2026
BREAKING: Fresenius Kabi has expanded its Simplist® ready-to-administer portfolio, introducing new presentations that extend its use into operating rooms and support clinicians in anesthesia and critical care. “These ready-to-administer medications reflect our ongoing commitment to support safe and efficient medication delivery,” said Arunesh Verma, President of Fresenius Kabi USA. Read the full news release: https://lnkd.in/euhapzax #FutureFresenius #CommittedToLife
- LINKEDIN · IMAGERecorded 19 Sept 2026
BREAKING: Fresenius Kabi has expanded its anti-infective portfolio with the introduction of Dalbavancin for Injection (for single-dose regimen use only), which is formulated, filled and packaged in the United States — reflecting our #MoreInAmerica commitment to strengthening U.S. manufacturing and supporting reliable access to clinical therapies. 🔗 Read the news release to learn more: https://lnkd.in/eEGVGmcJ Dalbavancin for Injection, for intravenous use IMPORTANT SAFETY INFORMATION Dalbavancin for Injection is a prescription intravenous (IV) antibiotic approved to treat certain types of bacterial infections called acute bacterial skin and skin structure infections (ABSSSI) in adult and pediatric patients. Dalbavancin for Injection should not be taken by anyone who has had a previous allergic (hypersensitivity) reaction to Dalbavancin for Injection. Serious allergic (hypersensitivity) reactions and skin reactions can occur with Dalbavancin for Injection. If Dalbavancin for Injection is administered rapidly, flushing of the upper body, hives, itching, rash, and/or back pain can occur. Diarrhea is a common problem caused by antibacterial drugs and usually resolves when the drug is discontinued. Tell your healthcare provider if you have kidney problems or have symptoms of liver diseases. The most common side effects of Dalbavancin for Injection in adult patients include nausea, headache, and diarrhea. The most common side effect in pediatric patients was fever. Contact your health care provider to learn more. For a more complete overview of the full risk profile, visit: https://lnkd.in/ejuUADU7 Intended for US audiences only. #FutureFresenius #CommittedToLife
- LINKEDIN · VIDEORecorded 19 Sept 2026
Thirteen new honorees have been inducted into the National Blood Donation Hall of Fame! Nominated by blood centers across the U.S., this year’s inductees include: ✅ Dedicated blood donors with hundreds of donations ✅ Advocates organizing drives in memory of loved ones ✅ Community leaders inspiring first-time donors Together, their stories showcase the powerful, personal reasons behind the decision to give. Learn more about the 2025 inductees: https://bit.ly/3LlHkuO. #BloodDonation #BloodDonationHallOfFame #CommittedToLife
- LINKEDIN · VIDEORecorded 19 Sept 2026
This Manufacturing Week, we’re proud to highlight the power of U.S. manufacturing at Fresenius Kabi. With nearly $1 billion invested in our three state-of-the-art pharmaceutical facilities in New York, Illinois, and North Carolina, we’re strengthening the resilience of our supply chain to help assure hospitals, clinics, and patients get the essential medicines they need, when they need them. Behind this progress is our team of operators, engineers, scientists, and more—working together to help set new standards in reliability, service, and patient care. 🏥 Because patients can’t wait. #TeamFresenius #CommittedToLife
- LINKEDIN · VIDEORecorded 19 Sept 2026
Take a look inside The Donor Room—where blood collection research and donor experience come together at our Lake Zurich, IL headquarters. Every donation here supports the design, testing, and refinement of blood collection technologies, helping make future donations safer, more comfortable, and more effective for donors and patients alike. Our dedicated professionals work closely with colleagues across disciplines to refine new devices and methods, always prioritizing the donor experience and patient needs. Their commitment to continuous improvement strengthens the foundation of healthcare and contributes to lasting advancements in transfusion medicine. Happy Blood Collectors Week to our incredible staff at The Donor Room—and thank you to our donors. Your commitment makes this vital work possible and strengthens the future of patient care. Learn more about The Donor Room: https://bit.ly/4pasJ4W. #BloodCollectorsWeek #CommittedToLife
6 of 24 adsSign up to see every Fresenius Kabi USA ad, filter by format and date, and get alerts on new ones.
See all 24 adsWatch the companies you care about.
Filter every ad by industry, country, format and network, and get alerts when a company you watch starts running new ads.